Level Bio AB (publ) (NGM:LEVBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3440
-0.0140 (-3.91%)
At close: Jun 30, 2025

Level Bio AB Revenue

Level Bio AB had revenue of 7.81M SEK in the quarter ending March 31, 2025, with 41.86% growth. This brings the company's revenue in the last twelve months to 27.40M, up 18.11% year-over-year. In the year 2024, Level Bio AB had annual revenue of 25.10M, down -3.83%.

Revenue (ttm)
27.40M
Revenue Growth
+18.11%
P/S Ratio
0.87
Revenue / Employee
2.74M
Employees
11
Market Cap
23.94M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202425.10M-999.39K-3.83%
Dec 31, 202326.10M-8.24M-23.99%
Dec 31, 202234.33M-9.63M-21.91%
Dec 31, 202143.96M20.43M86.86%
Dec 31, 202023.53M6.45M37.77%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Investor AB 104.49B
Atlas Copco AB 176.63B
AB Volvo 517.43B
EQT AB 30.39B
Skandinaviska Enskilda Banken AB 79.55B
ASSA ABLOY AB 152.90B
Swedbank AB 73.90B
Sandvik AB 123.18B
Revenue Rankings